Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease

The objective of the study was to investigate the kinetics and metabolism of caffeine in serum from patients with Parkinson disease (PD) and controls using liquid chromatography–mass spectrometry.

Original Source